Login / Signup

Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?

Didar Yanardag AcikMehmet BankirFiliz Alkan BaylanBilal Aygun
Published in: BMC cancer (2019)
This study highlights that ELA targeting may be a potential therapeutic option for treating CLL.
Keyphrases
  • cancer therapy
  • drug delivery
  • drug induced
  • replacement therapy